caa a22 4500 475802810 CHVBK 20180406123742.0 cr unu---uuuuu 170329e20001001xx s 000 0 eng 10.1007/s002680010205 doi (NATIONALLICENCE)springer-10.1007/s002680010205 Brawer Michael K. Northwest Prostate Institute, Pacific Northwest Cancer Foundation, 1560 North 115th Street, Suite 209, Seattle Washington 98133, USA, US aut Prostate Cancer: Where We Have Been, Where We Are, Where We AreGoing [Elektronische Daten] [Michael K. Brawer] Abstract : Prostate cancer has generated more debate over the last decade than perhaps any other malignancy. This stems from many factors, not the least of which is the fact that the histologic incidence far exceeds clinically manifested disease. Despite this fact, prostate cancer remains the most common male malignancy and the second most common cause of cancer-related mortality in most Western societies. Significant advances have occurred in virtually all domains surrounding prostate cancer, including increased understanding of the molecular and genetic basis of the disease, improved methods of early detection and screening, refinement of biopsy techniques, and advances in staging and therapeutic approaches. Even with these advances, the sobering mortality statistics clearly underscore the need for further insight and progress. by Société Internationale de Chirurgie, 2000 World Journal of Surgery Springer-Verlag 24/10(2000-10-01), 1200-1204 0364-2313 24:10<1200 2000 24 268 https://doi.org/10.1007/s002680010205 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s002680010205 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Brawer Michael K. Northwest Prostate Institute, Pacific Northwest Cancer Foundation, 1560 North 115th Street, Suite 209, Seattle Washington 98133, USA, US aut NATIONALLICENCE 773 0- World Journal of Surgery Springer-Verlag 24/10(2000-10-01), 1200-1204 0364-2313 24:10<1200 2000 24 268 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer